Overview Fundamentals API Earnings EOD API Sample Code Pricing

Avenue Therapeutics Inc (ATXI NASDAQ) stock market data APIs

$3.49 0.04(1.2%) as of July 19, 2024
Price chart is built with Anychart

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.

Avenue Therapeutics Inc Financial Data Overview

3 246 K
941 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ATXI',
Type: 'Common Stock',
Name: 'Avenue Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00GLTS4V4',
CIK: '1644963',
EmployerIdNumber: '47-4113275',
FiscalYearEnd: 'December',
IPODate: '2017-06-27',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Avenue Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share 12.67
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Avenue Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -9

Get Avenue Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?